Trial Profile
A randomized, double-blind, placebo-controlled study of gastroesophageal reflux disease therapy (lansoprazole; solutab) in the management of childhood asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2015
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 10 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (retrospective trial: NCT01536457).
- 10 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (retrospective trial: NCT01536457).
- 10 Feb 2015 Planned primary completion date changed to 1 Sep, 2012 as reported by ClinicalTrials.gov.